Abu dhabi: Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully completed 500 Transcatheter Aortic Valve Implantation (TAVI) procedures, marking a significant achievement in its delivery of cardiovascular care. This milestone underscores the hospital's role in pioneering minimally invasive treatments for aortic stenosis in the United Arab Emirates. According to Emirates News Agency, the Heart, Vascular and Thoracic Institute at Cleveland Clinic Abu Dhabi initiated TAVI procedures in 2015. This innovative technique has transformed the treatment of aortic stenosis by offering a less invasive alternative to traditional open-heart surgery. TAVI has proven crucial in improving outcomes for patients who are at higher risk for conventional surgical methods. Dr. George Haber, CEO of Cleveland Clinic Abu Dhabi, commented on the achievement, emphasizing the institution's commitment to advancing medical care through innovation. He highlighted the hospital's dedication to integrating expertise, technolog y, and a patient-first philosophy to reshape healthcare standards in the region. TAVI, also referred to as Transcatheter Aortic Valve Replacement (TAVR), addresses the condition where the aortic valve becomes narrowed, impeding blood flow from the heart. Symptoms of aortic stenosis include chest pain, shortness of breath, and fatigue. The TAVI procedure replaces the damaged valve with a bioprosthetic valve via a catheter in the upper thigh, significantly reducing recovery time compared to open-heart surgery. Dr. Gopal Bhatnagar, Chair of Cardiothoracic Surgery at the Heart, Vascular and Thoracic Institute, noted that reaching the 500-procedure mark is a testament to the team's dedication and expertise. Research indicates TAVI often surpasses the outcomes of surgical aortic valve replacement, with a success rate exceeding 98%, and benefits including higher survival rates, reduced stroke incidence, and shorter hospitalizations. The institute has expanded its cardiac surgery department, performing over 500 he art surgeries and 250 structural cases annually. In 2023, it introduced several innovative procedures and was designated a Centre of Excellence for adult cardiac surgery by the Department of Health - Abu Dhabi. The Heart, Vascular and Thoracic Institute continues to lead advancements in patient care in the UAE and the broader region. Cleveland Clinic Abu Dhabi remains committed to enhancing patient care through cutting-edge technology and a patient-centered approach. The completion of 500 TAVI procedures highlights the hospital's leadership in cardiovascular care and its dedication to improving patient health and well-being.